Table 1. Patients’ demographics and tumor’s characteristics.
Frequency | % | |
---|---|---|
Age (range) | 65 (18–88) | |
<70 | 260 | 65,5 |
> = 70 | 137 | 34,5 |
Gender | ||
Male | 246 | 62,0 |
Female | 151 | 38,0 |
Stage | ||
IIA-IIIC | 202 | 50,9 |
IV | 195 | 49,1 |
Location | ||
Colon/Sigmoid | 279 | 70,3 |
Rectum | 118 | 29,7 |
PS (ECOG) | ||
0–1 | 372 | 93,7 |
> = 2 | 25 | 6,3 |
Radiotherapy | ||
Yes | 80 | 20,4 |
No | 313 | 79,6 |
Adjuvant Treatment | ||
Yes | 230 | 58,7 |
No | 162 | 41,4 |
First Line Treatment | ||
Yes | 223 | 56,2 |
No | 174 | 46,8 |
Grade | ||
High | 205 | 47,4 |
Low | 228 | 52.6 |
TLR2 196-to -174 del | ||
ins/del | 93 | 23,4 |
del/del | 304 | 76,6 |
TLR4 Asp299Gly (A/G) | ||
AA | 11 | 2,8 |
AG | 106 | 26,7 |
GG | 280 | 70,5 |
TLR4 Thr399Ile (T/C) | ||
CC | 11 | 2,8 |
CT | 106 | 26,7 |
TT | 280 | 70,5 |
TLR9 T1237C | ||
TC | 153 | 38,5 |
CC | 244 | 61,5 |
TLR9 T1486C | ||
TC | 153 | 38,5 |
CC | 244 | 61,5 |
KRAS | ||
Mutant | 104 | 42,4 |
Wt | 141 | 57,6 |
ND | 152 |